Related Experiment Videos
Fibrotic valvular heart disease subsequent to bromocriptine treatment
Jacques Serratrice1, Patrick Disdier, Gilbert Habib
1Service de Médecine Interne, the Service de Cardiologie B, CHU Timone, Marseille Cedex 5, France.
Cardiology in Review
|October 23, 2002
Abstract:
Ergot alkaloids, such as ergotamine, have been associated with numerous vascular complications and with valvular heart disease. The authors describe a man who developed fibrosis of three heart valves during a 5-year treatment with bromocriptine for Parkinson disease. There were no other plausible causes. To our knowledge, such a side effect has never been described with this drug.